-
1دورية أكاديمية
المؤلفون: Liu, Sixue, Knochelmann, Hannah M, Lomeli, Shirley H, Hong, Aayoung, Richardson, Mary, Yang, Zhentao, Lim, Raymond J, Wang, Yan, Dumitras, Camelia, Krysan, Kostyantyn, Timmers, Cynthia, Romeo, Martin J, Krieg, Carsten, O’Quinn, Elizabeth C, Horton, Joshua D, Dubinett, Steve M, Paulos, Chrystal M, Neskey, David M, Lo, Roger S
المصدر: Cell Reports Medicine. 2(10)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Clinical Research, Immunotherapy, Cancer, Dental/Oral and Craniofacial Disease, Health Disparities, Rare Diseases, Minority Health, Antineoplastic Agents, Immunological, Carcinoma, Squamous Cell, Cyclin-Dependent Kinase Inhibitor p16, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Immune Checkpoint Inhibitors, Janus Kinase 2, Mouth Neoplasms, Mutation, Neoadjuvant Therapy, Neoplasm Recurrence, Local, Nivolumab, PTEN Phosphohydrolase, Programmed Cell Death 1 Receptor, Receptors, Antigen, T-Cell, alpha-beta, Survival Analysis, T-Lymphocytes, Regulatory, Th17 Cells, Treatment Outcome, Vascular Endothelial Growth Factor Receptor-3, YAP-Signaling Proteins, FLT4/PTEN/PPARG/CDKN2A/YAP1/JAK2, T cell repertoire, T regulatory to Th17 ratio, head-and-neck cancer/oral-cavity SCC, multiplex immunofluorescence, neoadjuvant anti-PD-1/L1 therapy, recurrence-free survival, response, resistance, and recurrence, tumor mutational burden, tumor phylogeny, Biomedical and clinical sciences
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/6fz2m57k
https://escholarship.org/content/qt6fz2m57k/qt6fz2m57k.pdf -
2دورية أكاديمية
المؤلفون: Sixue Liu, Hannah M. Knochelmann, Shirley H. Lomeli, Aayoung Hong, Mary Richardson, Zhentao Yang, Raymond J. Lim, Yan Wang, Camelia Dumitras, Kostyantyn Krysan, Cynthia Timmers, Martin J. Romeo, Carsten Krieg, Elizabeth C. O’Quinn, Joshua D. Horton, Steve M. Dubinett, Chrystal M. Paulos, David M. Neskey, Roger S. Lo
المصدر: Cell Reports Medicine, Vol 2, Iss 10, Pp 100411- (2021)
مصطلحات موضوعية: neoadjuvant anti-PD-1/L1 therapy, head-and-neck cancer/oral-cavity SCC, response, resistance, and recurrence, FLT4/PTEN/PPARG/CDKN2A/YAP1/JAK2, T cell repertoire, T regulatory to Th17 ratio, Medicine (General), R5-920
وصف الملف: electronic resource
-
3
المؤلفون: Roger S. Lo, S. Dubinett, Elizabeth C O'Quinn, Shirley H. Lomeli, Hannah M. Knochelmann, Mary S. Richardson, Raymond J. Lim, Cynthia D Timmers, Sixue Liu, Camelia Dumitras, David M. Neskey, Carsten Krieg, Aayoung Hong, Yan Wang, Martin J. Romeo, Kostyantyn Krysan, Chrystal M. Paulos, Joshua D. Horton, Zhentao Yang
المصدر: Cell Reports Medicine
Cell Reports Medicine, Vol 2, Iss 10, Pp 100411-(2021)مصطلحات موضوعية: Medicine (General), Receptors, Antigen, T-Cell, alpha-beta, Programmed Cell Death 1 Receptor, multiplex immunofluorescence, T-Lymphocytes, Regulatory, Antineoplastic Agents, Immunological, CDKN2A, Medicine, Immune Checkpoint Inhibitors, YAP1, biology, Neoadjuvant Therapy, Gene Expression Regulation, Neoplastic, Nivolumab, Treatment Outcome, tumor phylogeny, Carcinoma, Squamous Cell, Mouth Neoplasms, neoadjuvant anti-PD-1/L1 therapy, tumor mutational burden, General Biochemistry, Genetics and Molecular Biology, Article, R5-920, PTEN, Humans, recurrence-free survival, Oral Cavity Squamous Cell Carcinoma, Cyclin-Dependent Kinase Inhibitor p16, business.industry, Gene Expression Profiling, Head and neck cancer, T regulatory to Th17 ratio, PTEN Phosphohydrolase, FLT4/PTEN/PPARG/CDKN2A/YAP1/JAK2, YAP-Signaling Proteins, Janus Kinase 2, medicine.disease, Vascular Endothelial Growth Factor Receptor-3, FLT4, Survival Analysis, Blockade, Mutation, Cancer research, biology.protein, Th17 Cells, head-and-neck cancer/oral-cavity SCC, response, resistance, and recurrence, Neoplasm Recurrence, Local, business, T cell repertoire